AD80471
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1g | 98% | in stock | $16.00 | $11.00 | - + | |
5g | 98% | in stock | $40.00 | $28.00 | - + | |
25g | 98% | in stock | $105.00 | $73.00 | - + | |
100g | 98% | in stock | $297.00 | $208.00 | - + | |
500g | 98% | in stock | $1,131.00 | $792.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AD80471 |
Chemical Name: | 1-(4-(Piperidin-1-yl)phenyl)ethanone |
CAS Number: | 10342-85-5 |
Molecular Formula: | C13H17NO |
Molecular Weight: | 203.2802 |
MDL Number: | MFCD00006481 |
SMILES: | CC(=O)c1ccc(cc1)N1CCCCC1 |
NSC Number: | 102839 |
Complexity: | 213 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 2 |
XLogP3: | 3.1 |
1-(4-(Piperidin-1-yl)phenyl)ethanone, commonly referred to as $name$, is a versatile compound widely used in chemical synthesis. Its unique structure makes it a valuable building block in the creation of various pharmaceuticals, agrochemicals, and fine chemicals. In organic synthesis, $name$ serves as a key intermediate in the preparation of diverse molecules due to its functional groups and reactivity. Its ability to undergo various chemical transformations, such as nucleophilic additions and substitutions, enables chemists to introduce specific functional groups into target molecules efficiently. Through strategic manipulation of its structure, chemists can access a range of complex compounds with tailored properties and applications. By leveraging the synthetic potential of 1-(4-(Piperidin-1-yl)phenyl)ethanone, researchers can advance the development of novel drugs, materials, and other valuable products.
Acta crystallographica. Section E, Structure reports online 20120401
Acta crystallographica. Section E, Structure reports online 20100801
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030715
Biological & pharmaceutical bulletin 20021101